最新 Form 144 申報
公司的高階主管、董事與其他關係人要賣出受限制股票或控制股份，而且三個月內預計賣出超過 5,000 股或 5 萬美元時，下單時要交 Form 144。它是預計賣出的通知；高階主管、董事實際賣出之後，會再申報 Form 4。13D、13G 與 Form 144 是什麼
Form 144 申報
由新到舊。有 Form 144/A 修正的申報只列修正後的那一份。
近 365 天的申報（依美東日期）。
本站的 Form 144 申報：2023/1/4 到 2026/9/30。
市值明顯填錯的申報不列在這裡，也不算進合計；公司的頁面照樣列出並加註。判斷方式是把市值除以股數，得到的每股價格遠高於這家公司在預計賣出日前後的 Form 4 成交價與 13F 持股的價格，就當成填錯。
- 申報份數
- 25
- 預計賣出市值
- $9,389 萬
- 賣方
- 7
- 公司
- 1
- 依 10b5-1 計畫
- 7
| 公司 | 申報時間（美東） | 賣方 | 預計賣出股數 | 市值 | 預計賣出日 | 券商 | 原文 |
|---|---|---|---|---|---|---|---|
| PTGXProtagonist Therapeutics, Inc | 2026/9/3016:20 ET | Asif Ali高階主管 | 5.86 萬 | $826.5 萬 | 2026/9/3010b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| PTGXProtagonist Therapeutics, Inc | 2026/8/1016:49 ET | Dinesh PatelCEO | 22.5 萬 | $3,358 萬 | 2026/8/1010b5-1 | J.P. Morgan Securities LLC | SEC |
| PTGXProtagonist Therapeutics, Inc | 2026/6/2316:27 ET | William Waddill董事 | 9,000 | $103.5 萬 | 2026/6/2310b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| PTGXProtagonist Therapeutics, Inc | 2026/6/1016:29 ET | William Waddill董事 | 9,000 | $95.3 萬 | 2026/6/1010b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| PTGXProtagonist Therapeutics, Inc | 2026/5/2916:23 ET | William Waddill董事 | 9,000 | $90.4 萬 | 2026/5/2910b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| PTGXProtagonist Therapeutics, Inc | 2026/5/1217:29 ET | Dinesh PatelCEO | 7.50 萬 | $776.3 萬 | 2026/5/1210b5-1 | J.P. Morgan Securities LLC | SEC |
| PTGXProtagonist Therapeutics, Inc | 2026/5/816:23 ET | Bryan M & Courtney L Giraudo RT董事 | 1.11 萬 | $111.3 萬 | 2026/5/8 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| PTGXProtagonist Therapeutics, Inc | 2026/5/717:21 ET | Bryan Giraudo董事 | 3.60 萬 | $360.5 萬 | 2026/5/7 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| PTGXProtagonist Therapeutics, Inc | 2026/5/716:49 ET | Bryan M & Courtney L Giraudo RT董事 | 1.20 萬 | $120.1 萬 | 2026/5/7 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| PTGXProtagonist Therapeutics, Inc | 2026/4/2116:57 ET | Asif Ali高階主管 | 1,750 | $18.5 萬 | 2026/4/20 | Morgan Stanley Smith Barney Operations Department | SEC |
| PTGXProtagonist Therapeutics, Inc | 2026/3/2616:05 ET | Harold Selick董事 | 2.40 萬 | $252.0 萬 | 2026/3/26 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| PTGXProtagonist Therapeutics, Inc | 2026/3/2616:05 ET | Asif Ali高階主管 | 2.48 萬 | $258.2 萬 | 2026/3/26 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| PTGXProtagonist Therapeutics, Inc | 2026/3/2616:01 ET | Arturo Molina高階主管 | 1.50 萬 | $157.2 萬 | 2026/3/26 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| PTGXProtagonist Therapeutics, Inc | 2026/3/2417:56 ET | Dinesh PatelCEO | 5.47 萬 | $539.0 萬 | 2026/3/24 | J.P. Morgan Securities LLC | SEC |
| PTGXProtagonist Therapeutics, Inc | 2026/2/1717:27 ET | Lewis T Williams董事 | 1.80 萬 | $148.3 萬 | 2026/2/17 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| PTGXProtagonist Therapeutics, Inc | 2026/2/616:04 ET | William D Waddill董事 | 2.00 萬 | $167.4 萬 | 2026/2/6 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| PTGXProtagonist Therapeutics, Inc | 2026/1/2717:12 ET | Asif Ali高階主管 | 4.62 萬 | $384.1 萬 | 2026/1/27 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| PTGXProtagonist Therapeutics, Inc | 2026/1/2716:01 ET | Arturo Molina高階主管 | 5,000 | $41.0 萬 | 2026/1/27 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| PTGXProtagonist Therapeutics, Inc | 2026/1/2616:29 ET | Arturo Molina高階主管 | 5,000 | $41.1 萬 | 2026/1/26 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| PTGXProtagonist Therapeutics, Inc | 2026/1/2316:32 ET | Arturo Molina高階主管 | 1.32 萬 | $109.7 萬 | 2026/1/23 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| PTGXProtagonist Therapeutics, Inc | 2026/1/2316:06 ET | Dinesh PatelCEO | 10.8 萬 | $916.2 萬 | 2026/1/23 | J.P. Morgan Securities LLC | SEC |
| PTGXProtagonist Therapeutics, Inc | 2026/1/2117:12 ET | Arturo Molina MD高階主管 | 9,514 | $78.5 萬 | 2026/1/20 | Morgan Stanley Smith Barney Operations Department | SEC |
| PTGXProtagonist Therapeutics, Inc | 2026/1/2117:11 ET | Dinesh V Patel PH DOfficer, Director | 3.44 萬 | $284.0 萬 | 2026/1/20 | Morgan Stanley Smith Barney Operations Department | SEC |
| PTGXProtagonist Therapeutics, Inc | 2026/1/2117:10 ET | Asif Ali高階主管 | 8,588 | $70.8 萬 | 2026/1/20 | Morgan Stanley Smith Barney Operations Department | SEC |
| PTGXProtagonist Therapeutics, Inc | 2025/10/1016:18 ET | William Waddill董事 | 1.20 萬 | $80.4 萬 | 2025/10/1010b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |